Skip to main content

Articles

Page 13 of 13

  1. Clofarabine alone or in combination with cyclophosphamide and etoposide has shown a good efficacy and a tolerable toxicity profile in previous studies of children with relapsed or refractory leukaemia. This re...

    Authors: Pascale Trioche, Brigitte Nelken, Gérard Michel, Isabelle Pellier, Arnaud Petit, Yves Bertrand, Pierre Rohrlich, Claudine Schmitt, Nicolas Sirvent, Patrick Boutard, Geneviève Margueritte, Brigitte Pautard, Stéphane Ducassou, Dominique Plantaz, Alain Robert, Caroline Thomas…
    Citation: Experimental Hematology & Oncology 2012 1:39
  2. Intravascular diffuse large B-cell lymphoma limited to the CNS (cIVL) is a very rare malignant disorder characterized by a selective accumulation of neoplastic lymphocytes (usually B cells) within the lumen of...

    Authors: Sied Kebir, Klaus Kuchelmeister, Pitt Niehusmann, Michael Nelles, Young Kim, Sharmilan Thanendrarajan, Niklas Schäfer, Moritz Stuplich, Frederic Mack, Björn Scheffler, Horst Urbach, Martin Glas and Ulrich Herrlinger
    Citation: Experimental Hematology & Oncology 2012 1:37
  3. Repeated administration of antibody-based therapies such as radioimmunotherapy depends on preserved antigen expression in tumor lesions. The purpose of this study was to evaluate whether the antigen expression...

    Authors: Erika Elgström, Sophie E Eriksson, Tomas G Ohlsson, Jan Tennvall and Rune Nilsson
    Citation: Experimental Hematology & Oncology 2012 1:34
  4. The amplification of putative oncogenes is a common finding within the genome of various cancer types. Identification and further targeting of specific junction sites within the sequence of genomic amplicons (...

    Authors: Axel Weber, Sylvia Taube, Udo zur Stadt, Martin Horstmann, Knut Krohn, Jutta Bradtke, Andrea Teigler-Schlegel, Sabine Leiblein and Holger Christiansen
    Citation: Experimental Hematology & Oncology 2012 1:33
  5. Therapy of indolent lymphomas with involvement of the central nervous system (CNS) has not been standardized so far. A 42-year old male patient presented with neurological signs because of leukemic splenic mar...

    Authors: Christoph Busemann, Andrej Gudzuhn, Carsten Hirt, Michael Kirsch, Silke Vogelgesang, Christian A Schmidt, Gottfried Dölken and William H Krüger
    Citation: Experimental Hematology & Oncology 2012 1:32
  6. Radiation therapy (RT) after breast conservation therapy has recently been linked with significant reduction in risk of ipsilateral breast cancer among BRCA1 mutation carriers. However, the exact mechanism by whi...

    Authors: Huai-Chin Chiang, Sreejith J Nair, I-Tien Yeh, Alfredo A Santillan, Yanfen Hu, Richard Elledge and Rong Li
    Citation: Experimental Hematology & Oncology 2012 1:31
  7. The treatment strategy for gastric diffuse large cell lymphoma (DLBCL) has not been standardized in such as to the cycles of chemotherapy, dose of radiation, or necessity for the surgery. Although the results ...

    Authors: Yuko Mishima, Yasuhito Terui, Masahiro Yokoyama, Noriko Nishimura, Sakura Sakajiri, Kyoko Ueda, Yasutoshi Kuboki, Kenji Nakano, Kazuhito Suzuki, Eriko Nara, Naoko Tsuyama, Kengo Takeuchi, Masahiko Oguchi and Kiyohiko Hatake
    Citation: Experimental Hematology & Oncology 2012 1:30
  8. We report the successful treatment and sustained molecular remission using single agent nilotinib in a relapsed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia patient after allogeneic hema...

    Authors: Paul Farnsworth, David Ward and Vijay Reddy
    Citation: Experimental Hematology & Oncology 2012 1:29
  9. Chronic lymphocytic leukemia (CLL) rarely exhibits an aggressive clinical course and its patients often have chromosomal deletions or additions. Furthermore, reciprocal translocations are barely observed in CL...

    Authors: Kayo Harada, Kazuhiko Ikeda, Hayato Matsumoto, Miki Furukawa, Hiroshi Takahashi, Hiroshi Ohkawara, Hideyoshi Noji, Kazuhiro Tasaki, Masafumi Abe, Kazuei Ogawa and Yasuchika Takeishi
    Citation: Experimental Hematology & Oncology 2012 1:28
  10. Multiple myeloma is an incurable malignant disorder of mature B-cells that predominantly affects the elderly. The immunomodulatory drug (IMiD) thalidomide and its newer analogs demonstrate increased antitumor ...

    Authors: Tahir Latif, Nabeel Chauhan, Rashid Khan, Andrea Moran and Saad Z Usmani
    Citation: Experimental Hematology & Oncology 2012 1:27
  11. Paroxysmal nocturnal hemoglobinuria (PNH) is a progressive, life-threatening disorder characterized by chronic intravascular hemolysis caused by uncontrolled complement activation. Hepatic vein thrombosis (Bud...

    Authors: Andrés Brodsky, Octavio Mazzocchi, Fabiana Sánchez, Gus Khursigara, Suneil Malhotra and Mariano Volpacchio
    Citation: Experimental Hematology & Oncology 2012 1:26
  12. Inhibitors of apoptosis (IAPs) were intensively investigated in the context of cancer where they promote tumor growth and chemoresistence. Overexpression of the IAP BIRC6 is associated with unfavorable clinical f...

    Authors: Anna M Schläfli, Bruce E Torbett, Martin F Fey and Mario P Tschan
    Citation: Experimental Hematology & Oncology 2012 1:25
  13. Extreme swing of phosphor from severe hyperphosphatemia to severe hypophosphatemia in a patient with blast crisis of myeloid origin was the result of imbalance between massive apoptosis of leukemic cells in th...

    Authors: Ophira Salomon, Eli J Holtzman, Pazit Beckerman, Camila Avivi, Luba Trakhtenbrot, Abraham Kneller, Tali Tohami, Yeroham Kleinbaum, Sara Apter, Ninette Amariglio, Ehud Grossman and Ginette Schiby
    Citation: Experimental Hematology & Oncology 2012 1:24
  14. The computational fluid dynamics method, which provides an estimation of the pressure drop in the airway before and after the stent implantation, is proposed in this study. This method is based on the finite v...

    Authors: Chien-Yi Ho, Hsiu-Mei Liao, Chih-Yen Tu, Chih-Yang Huang, Chuen-Ming Shih, Min-Ying Lydia Su, Jeon-Hor Chen and Tzu-Ching Shih
    Citation: Experimental Hematology & Oncology 2012 1:23
  15. The B-cell leukemia/lymphoma 11B (BCL11B) gene is a member of the BCL family which plays a crucial role in the development, proliferation, differentiation and subsequent survival of T cells. BCL11B gene altera...

    Authors: Xin Huang, Xin Du and Yangqiu Li
    Citation: Experimental Hematology & Oncology 2012 1:22
  16. T-cell prolymphocytic leukemia (T-PLL) is a rare form of leukemia composed of mature T-cells that usually presents in older people with a median age of 65. Most cases of T-PLL will harbor chromosomal abnormali...

    Authors: Carlos A Tirado, Phillip Starshak, Paul Delgado and Nagesh Rao
    Citation: Experimental Hematology & Oncology 2012 1:21
  17. Two major types of amyloidosis are primary amyloidosis or amyloid light chain amyloidosis and secondary amyloidosis. Although amyloidosis involves a variety of organ systems including skin, the occurrence of b...

    Authors: Aref Agheli, Marvin Becker, Gary Becker, M Rashid Chaudhry and Jen C Wang
    Citation: Experimental Hematology & Oncology 2012 1:19
  18. The transcription factor E2F1 has been implicated in cell cycle control and DNA damage response. Paradoxically, E2F1 can promote apoptosis and function as tumor suppressor. In non-small cell lung cancer (NSCLC...

    Authors: Jung-Jyh Hung, Chung-Tsen Hsueh, Kuan-Hua Chen, Wen-Hu Hsu and Yu-Chung Wu
    Citation: Experimental Hematology & Oncology 2012 1:18
  19. Tyrosine kinase inhibitors specific for BCR-ABL, were a major breakthrough in CML therapy. Second generation tyrosine kinase inhibitors (dasatinib, nilotinib) are indicated for imatinib resistant and intoleran...

    Authors: Klára Gadó, András Matolcsy, Judit Csomor, Dóra Kicsi, Csaba Bödör and Gyula Domján
    Citation: Experimental Hematology & Oncology 2012 1:17
  20. A 57-year-old male with a history of hypertension presented with shortness of breath, intermittent substernal chest pain, subjective fevers, and a 30-pound weight loss. He was found to have a bladder mass four...

    Authors: Joshua R Peck, Charles L Hitchcock, Sara Maguire, Jennifer Dickerson and Charles Bush
    Citation: Experimental Hematology & Oncology 2012 1:16
  21. JAK2V617F, a gain-of-function mutant form of tyrosine kinase JAK2, is found in the majority of patients with Ph- myeloproliferative neoplasms (MPNs), a group of chronic hematological diseases that often lead t...

    Authors: Wanke Zhao, Yanhong Du, Wanting Tina Ho, Xueqi Fu and Zhizhuang Joe Zhao
    Citation: Experimental Hematology & Oncology 2012 1:15
  22. Stromal or mesenchymal neoplasms affecting the gastrointestinal (GI) tract have undergone a remarkable evolution in how they are perceived, classified, approached, diagnosed and managed over the last 30 years....

    Authors: Gurpreet Lamba, Ridhi Gupta, Byung Lee, Samir Ambrale and Delong Liu
    Citation: Experimental Hematology & Oncology 2012 1:14
  23. We present our initial experience of allogeneic stem cell transplant procedure performed between April 2004 and August 2011 for various haematological disorders. All patients with non-malignant and malignant h...

    Authors: Natasha Ali, Salman Naseem Adil, Mohammad Usman Shaikh, Munira Moosajee and Nehal Masood
    Citation: Experimental Hematology & Oncology 2012 1:13
  24. Hematopoietic stem cells (HSCs) are rare cells that have the unique ability to self-renew and differentiate into cells of all hematopoietic lineages. The expansion of HSCs has remained an important goal to dev...

    Authors: Jessica A Schuster, Maria R Stupnikov, Gina Ma, Wenbin Liao, Raymond Lai, Yupo Ma and Jerell R Aguila
    Citation: Experimental Hematology & Oncology 2012 1:12
  25. Liposomal formulations of anthracyclines appear to have favorable toxicity profile when compared with conventional anthracyclines in elderly, high risk cardiac patients and patients with prior use of anthracyc...

    Authors: Shamudheen M Rafiyath, Mohammad Rasul, Byung Lee, Guoqing Wei, Gurpreet Lamba and Delong Liu
    Citation: Experimental Hematology & Oncology 2012 1:10
  26. HevyLite™ is a new, recently developed method that facilitates separate quantification of the kappa- and lambda-bounded amounts of a given immunoglobulin (Ig). Using this method, we measured intact immunoglobu...

    Authors: Efstathios Koulieris, Panayiotis Panayiotidis, Stephen J Harding, Nikolitsa Kafasi, Dimitris Maltezas, Vassiliki Bartzis, Tatiana Tzenou, Maria Dimou, George Georgiou, Ladan Mirbahai, Arthur R Bradwell and Marie-Christine Kyrtsonis
    Citation: Experimental Hematology & Oncology 2012 1:9
  27. A patient with acute lymphoblastic leukemia repeatedly developed hypoglycemia during chemotherapy. Comparison of serum glucose trends between chemotherapy with and without L-asparaginase (L-Asp) demonstrated a...

    Authors: Ryuma Tanaka, Tomoo Osumi, Masashi Miharu, Tomohiro Ishii, Tomonobu Hasegawa, Takao Takahashi and Hiroyuki Shimada
    Citation: Experimental Hematology & Oncology 2012 1:8
  28. T-cell Prolymphocytic leukemia (T-PLL) is a rare post-thymic T-cell malignancy that follows an aggressive clinical course. The classical presentation includes an elevated white blood cell (WBC) count with anem...

    Authors: Michael Bellone, Annika M Svensson, Ann-Leslie Zaslav, Silvia Spitzer, Marc Golightly, Mahmut Celiker, Youjun Hu, Yupo Ma and Tahmeena Ahmed
    Citation: Experimental Hematology & Oncology 2012 1:7
  29. This report describes the clinical courses of two acute myeloid leukemia patients. Both had MLL translocations, the first a t(10;11)(p11.2;q23) with MLL-AF10 and the second a t(11;19)(q23;p13.1) with MLL-ELL fusi...

    Authors: Thomas Burmeister, Mara Molkentin, Claus Meyer, Nils Lachmann, Stefan Schwartz, Birte Friedrichs, Jörg Beyer, Igor Wolfgang Blau, Gunnar Lohm, Carola Tietze-Bürger, Rolf Marschalek and Lutz Uharek
    Citation: Experimental Hematology & Oncology 2012 1:6
  30. Angiogenesis is essential for promoting growth and metastasis of solid tumors by ensuring blood supply to the tumor mass. Targeting angiogenesis is therefore an attractive approach to therapeutic intervention ...

    Authors: Dazhong Xu, Qi Wang, Yongping Jiang, Yanxi Zhang, Eleazar Vega-SaenzdeMiera, Iman Osman and Wei Dai
    Citation: Experimental Hematology & Oncology 2012 1:5
  31. A growing body of evidence indicates that digitoxin cardiac glycoside is a promising anticancer agent when used at therapeutic concentrations. Digitoxin has a prolonged half-life and a well-established clinica...

    Authors: Hosam A Elbaz, Todd A Stueckle, William Tse, Yon Rojanasakul and Cerasela Zoica Dinu
    Citation: Experimental Hematology & Oncology 2012 1:4
  32. Oxidative stress and redox-regulating enzymes may have roles both in lymphomagenesis and resistance to lymphoma therapy. Previous studies from the pre-rituximab era suggest that antioxidant enzyme expression i...

    Authors: Pekka Peroja, Anna Kaisa Pasanen, Kirsi-Maria Haapasaari, Esa Jantunen, Ylermi Soini, Taina Turpeenniemi-Hujanen, Risto Bloigu, Laura Lilja, Outi Kuittinen and Peeter Karihtala
    Citation: Experimental Hematology & Oncology 2012 1:2

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 9.4
    5-year Journal Impact Factor: 8.3
    Source Normalized Impact per Paper (SNIP): 1.583
    SCImago Journal Rank (SJR): 2.384

    Speed 2023
    Submission to first editorial decision (median days): 2
    Submission to acceptance (median days): 100

    Usage 2023
    Downloads: 696,150
    Altmetric mentions: 375